Penn Herb Wellness Guide
Advair Diskus
Common brand names:
Advair Diskus, Advair HFAThis drug combines two primary active ingredients: salmeterol and fluticasone.
Salmeterol is a member of the drug family known as long-acting, beta-adrenergic bronchodilators (also called beta-agonists). It is inhaled by mouth, into the lungs, to treat asthma and prevent bronchospasm. Salmeterol is also used to prevent exercise-induced bronchospasm.
Fluticasone is a type of corticosteroid that is inhaled by mouth to treat and prevent asthma, as well as other inflammatory conditions of the lungs that restrict breathing. Oral corticosteroids are inhaled into the nose to treat and prevent symptoms of hay fever and other allergies, and somemay be used to prevent recurrence of nasal polyps after surgical removal.
Some of the information in this article pertains to inhaled corticosteroids in general, not fluticasone specifically. The interactions reported here may not apply to all the Also Indexed As terms. Talk to your doctor or pharmacist if you are taking any of these drugs.
Summary of Interactions with Vitamins, Herbs, & Foods
 Reduce Side Effects | none |
| Support Medicine
|
 Reduces Effectiveness
| none |
| Potential Negative Interaction
| none |
 Explanation Required
|
Copyright 2024 TraceGains, Inc. All rights reserved.
RxAnswers is a copyrighted product from TraceGains.
This information is intended only for residents of the United States. Products sold under the same brand names in other countries may contain different ingredients.
There are some limitations on the information provided in “Nutrient Interactions.” Do NOT rely solely on the information in this article. Please read the disclaimer.
Learn more about TraceGains, the company.
Learn more about the authors of RxAnswers.
TraceGains and/or its suppliers make no warranties or representations as to the accuracy or completeness of this content herein or that of any organization referred or linked to within this content and will not be liable for any damages arising out of your access to or use of any information found herein or that of any organization referred to within this content.
Information expires December 2024.